|
|
||||||||||
|
J Am Coll Cardiol, 2001; 38:1829-1835 © 2001 by the American College of Cardiology Foundation |
a ANMCO Research Center, Via La Marmora, 36 Firenze, Italy. Please see for MAVI Study Group participants
Manuscript received December 30, 2000; revised manuscript received August 14, 2001, accepted August 29, 2001.
* Reprint requests and correspondence: Dr. Paolo Verdecchia, ANMCO Research Center, Via La Marmora, 39, 50121-Firenze, Italy
verdec{at}tin.it
OBJECTIVES
This study investigated the prognostic value of left ventricular (LV) mass at echocardiography in uncomplicated subjects with essential hypertension.
BACKGROUND
Only a few single-center studies support the prognostic value of LV mass in uncomplicated hypertension.
METHODS
The MAssa Ventricolare sinistra nellIpertensione study was a multicenter (45 centers) prospective study. The prespecified aim was to explore the prognostic value of LV mass in hypertension. Admission criteria included essential hypertension, no previous cardiovascular events, and age
50. There was central reading of echocardiographic tracings. Treatment was tailored to the single subject.
RESULTS
Overall, 1,033 subjects (396 men) were followed for 0 to 4 years (median, 3 years). Mean age at entry was 60 years, and systolic/diastolic blood pressure was 154/92 mm Hg. The rate of cardiovascular events (x100 patient-years) was 1.3 in the group with normal LV mass and 3.2 in the group (28.5% of total sample) with LV mass
125 g/body surface area (p = 0.005). After adjustment for age (p < 0.01), diabetes (p < 0.01), cigarette smoking (p < 0.01) and serum creatinine (p = 0.03), LV hypertrophy was associated with an increased risk of events (RR [relative risk] 2.08; 95% CI [confidence interval]: 1.22 to 3.57). For each 39 g/m2 (1 SD) increase in LV mass there was an independent 40% rise in the risk of major cardiovascular events (95% CI: 14 to 72; p = 0.0013).
CONCLUSIONS
Our findings show a strong, continuous and independent relationship of LV mass to subsequent cardiovascular morbidity. This is the first study to extend such demonstration to a large nationwide multicenter sample of uncomplicated subjects with essential hypertension.
| ||||||||||||||||
This article has been cited by other articles:
![]() |
J. A. Hill and E. N. Olson Cardiac Plasticity N. Engl. J. Med., March 27, 2008; 358(13): 1370 - 1380. [Full Text] [PDF] |
||||
![]() |
K. Taniguchi, T. Takahashi, K. Toda, H. Matsue, Y. Shudo, H. Shintani, M. Mitsuno, and Y. Sawa Left ventricular mass: impact on left ventricular contractile function and its reversibility in patients undergoing aortic valve replacement Eur. J. Cardiothorac. Surg., October 1, 2007; 32(4): 588 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mehta, J. E. Rame, A. Khera, S. A. Murphy, R. M. Canham, R. M. Peshock, J. A. de Lemos, and M. H. Drazner Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation Hypertension, June 1, 2007; 49(6): 1385 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Elias, L. M. Sullivan, P. K. Elias, R. B. D'Agostino Sr, P. A. Wolf, S. Seshadri, R. Au, E. J. Benjamin, and R. S. Vasan Left Ventricular Mass, Blood Pressure, and Lowered Cognitive Performance in the Framingham Offspring Hypertension, March 1, 2007; 49(3): 439 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Heckbert, W. Post, G. D.N. Pearson, D. K. Arnett, A. S. Gomes, M. Jerosch-Herold, W. G. Hundley, J. A. Lima, and D. A. Bluemke Traditional Cardiovascular Risk Factors in Relation to Left Ventricular Mass, Volume, and Systolic Function by Cardiac Magnetic Resonance Imaging: The Multiethnic Study of Atherosclerosis J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2285 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schalla, C. B. Higgins, M. Chujo, and M. Saeed Effect of Potassium-Channel Opener Therapy on Reperfused Infarction in Hypertrophied Hearts: Demonstration of Preconditioning by Using Functional and Contrast-Enhanced Magnetic Resonance Imaging Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 193 - 202. [Abstract] [PDF] |
||||
![]() |
M. P. Schneider, A. U. Klingbeil, C. Delles, M. Ludwig, R. E. Kolloch, M. Krekler, K. O. Stumpe, and R. E. Schmieder Effect of Irbesartan Versus Atenolol on Left Ventricular Mass and Voltage: Results of the CardioVascular Irbesartan Project Hypertension, July 1, 2004; 44(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pacifico and P. D. Henry Ablation for atrial fibrillation: are cures really achieved? J. Am. Coll. Cardiol., June 2, 2004; 43(11): 1940 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ogita, K. Node, Y. Liao, F. Ishikura, S. Beppu, H. Asanuma, S. Sanada, S. Takashima, T. Minamino, M. Hori, et al. Raloxifene Prevents Cardiac Hypertrophy and Dysfunction in Pressure-Overloaded Mice Hypertension, February 1, 2004; 43(2): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G Friedrich, B. Dahlof, U. Sechtem, T. Unger, M. Knecht, R. Dietz, and TELMAR Investigators Telmisartan Effectiveness on Left ventricular MAss Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension -- a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months -- rationale and study design Journal of Renin-Angiotensin-Aldosterone System, December 1, 2003; 4(4): 234 - 243. [Abstract] [PDF] |
||||
![]() |
G. de Simone Left Ventricular Geometry and Hypotension in End-Stage Renal Disease: A Mechanical Perspective J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2421 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.D McGavigan, F.G Dunn, and N.E.R Goodfield Secondary harmonic imaging overestimates left ventricular mass compared to fundamental echocardiography Eur J Echocardiogr, September 1, 2003; 4(3): 178 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Leoncini, F. Viazzi, D. Parodi, S. Vettoretti, E. Ratto, M. Ravera, C. Tomolillo, M. Del Sette, G. P. Bezante, G. Deferrari, et al. Mild Renal Dysfunction and Subclinical Cardiovascular Damage in Primary Hypertension Hypertension, July 1, 2003; 42(1): 14 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, D. Carreras, and A. J. de Bold Discoordinate re-expression of cardiac fetal genes in N{omega}-nitro-L-arginine methyl ester (L-NAME) hypertension Cardiovasc Res, January 1, 2003; 57(1): 158 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Simone, P. Verdecchia, S. Pede, M. Gorini, and A. P. Maggioni Prognosis of Inappropriate Left Ventricular Mass in Hypertension: The MAVI Study Hypertension, October 1, 2002; 40(4): 470 - 476. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |